Federal health agencies 2015 year in review


This was an exceptional year for publicly-funded research projects. Investments in science led to a greater understanding of preventing and treating disease such as using genetic variants to identify people at risk for coronary heart disease and tailoring breast cancer treatments to avoid the need for chemotherapy. The National Institutes of Health (NIH) also supported the work of three Nobel Prize winners and clinical advances in cancer, heart disease, MS and many other conditions. The National Science Foundation (NSF) funded interdisciplinary projects including one that led to a holistic approach to strengthening the security and effectiveness of mobile medical applications. Evidence-based tools to improve patient care also helped to advance medical progress. The Agency for Healthcare Research and Quality’s (AHRQ) continues to elevate the quality of health care delivery across the country. Below is a year-end roundup of research highlights from the NIH, NSF, CDC, FDA, and AHRQ. 

NIH Research Highlights and Clinical Breakthroughts

NSF Discoveries

CDC Year in Review: What’s Next?

 FDA: A Look Back (and Ahead) Medical Product Innovation

AHRQ Impact Case Studies

To build on this momentum, policymakers must commit to sustained and predictable funding for the federal health and science agencies, and support policies that fortify the research continuum through discovery, development and delivery. Tell your elected officials to make research for health a higher national priority in FY17! 

Add comment

Plain text

  • No HTML tags allowed.
  • Adds node titles to internal links found in content (as HTML "title" attribute).
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Without continued support for health research, many of the most promising young scientists, their ideas and a myriad of potentially life-changing scientific breakthroughs will vanish into oblivion.
Paul Marinec, PhD; University of California San Francisco